机构:[1]Department of Health Research Methods, Evidence and Impact Canada, McMaster University, Hamilton, Ont.[2]Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China医技科室(本部)药事部(本部)北京朝阳医院[3]Department of Medicine, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ont.[4]Department of Critical Care Medicine and Sunnybrook Research Institute , Sunnybrook Health Sciences Centre, Toronto, Ont.[5]Department of Pediatrics, University of British Columbia, Vancouver, BC[6]Department of Medicine, Université de Sherbrooke[7]Centre de recherche du CHUS de Sherbrooke, Sherbrooke, Que.[8]Department of Critical Care Medicine, Zhongda hospital, School of Medicine, Southeast University, Nanjing, China[9]Department of Pharmacy, the First Affiliated Hospital of Guangzhou University of Medical[10]Department of Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou, China[11]Department of Pathology and Molecular Medicine and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ont.[12]Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China[13]Guangdong kuaiwen information technology co. LTD, Guanzhong, China[14]Kunshan Guanghui Precise Metal Co. Ltd., Kunshan, China[15]Intensive Care Department , King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia[16]Department of Clinical Medicine, Health Science Center, Universidad de Guadalajara, Guadalajara, Mexico[17]Department of Critical Care Medicine, Xuanwu Hospital, Capital Medical School, Beijing, China首都医科大学宣武医院重症医学科[18]Department of Pulmonary and Critical Care Medicine , University of Ulsan College of Medicine, Seoul, South Korea[19]Department of Pharmacy , Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China[20]Department of Pharmacy, Peking University Third Hospital, Beijing, China[21]Fast and Chronic Programmes, Alexandra Hospital, National University Health System, Singapore[22]Department of Pharmacy, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China[23]General Surgery Department, Peking University Third Hospital, Beijing, China[24]Medical Intensive Care Unit , Peking Union Medical College Hospital, Beijing.[25]Department of Medicine, McMaster University, Hamilton, Ont.
第一作者机构:[1]Department of Health Research Methods, Evidence and Impact Canada, McMaster University, Hamilton, Ont.
通讯作者:
推荐引用方式(GB/T 7714):
Ye Zhikang,Rochwerg Bram,Wang Ying,et al.Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.[J].CANADIAN MEDICAL ASSOCIATION JOURNAL.2020,192(20):E536-E545.doi:10.1503/cmaj.200648.
APA:
Ye Zhikang,Rochwerg Bram,Wang Ying,Adhikari Neill K,Murthy Srinivas...&Guyatt Gordon H.(2020).Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline..CANADIAN MEDICAL ASSOCIATION JOURNAL,192,(20)
MLA:
Ye Zhikang,et al."Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.".CANADIAN MEDICAL ASSOCIATION JOURNAL 192..20(2020):E536-E545